Upcoming Programs and Events
The Herbert Irving Comprehensive Cancer Center hosts a variety of programs and events for our members, patients, and community.
If you would like your event posted on this webpage, please contact the Communications Office at cucancercomms@cumc.columbia.edu.
-
Categories
- College of Physicians and Surgeons
Craig T. Jordan, Ph.D.
Chief, Division of Hematology
Vice Chair for Basic Science, Dept of Medicine
University of Colorado Denver
Title: Metabolic vulnerabilities of tumor-initiating cells in myeloid pathogenesis
Description: Cancers arising from varying stages of myeloid development possess distinct properties that represent opportunities for therapeutic intervention. This presentation will describe metabolic vulnerabilities in tumor-initiating cells that occur in myelodysplastic syndrome (MDS), de novo acute myeloid leukemia (AML), and relapsed/refractory AML.
Host: Stavroula Kousteni, PhD
-
Categories
- College of Physicians and Surgeons
Gary W. Miller, PhD
Professor of Environmental Health Sciences
Department of Environmental Health Sciences
Program: Cancer Population Science
Title: "Using exposomics to uncover the environmental contributors to cancer"
Description of talk: Advances in high-resolution mass spectrometry (HRMS) have led to an increased ability to measure small molecules in biological samples. Although the field of metabolomics has progressed in its ability to measure endogenous small molecules, little attention has been given to the detection of environmental chemicals and other xenobiotics in human samples using these high-resolution approaches. HRMS provides an excellent means for measuring the exposome, which is defined as the integrated compilation of the physical, chemical, biological, and psychosocial factors that contribute to disease. Dr. Miller’s team has used exposomics to study a range of human diseases, such as Alzheimer’s disease and Parkinson’s disease. His team is part of a recently awarded Cancer Grand Challenge grant (SAMBAI) designed to study cancer health disparities (breast, prostate, and pancreatic) in the African diaspora with participants from Ghana, Nigeria, Ethiopia, Kenya, South Africa, the UK, and the U.S. Dr. Miller will discuss ongoing studies and the proposed cancer studies that will be performed under SAMBAI.
Via Zoom
Meeting ID: 999 0430 6839
PW: seminar
https://columbiacuimc.zoom.us/j/99904306839?pwd=TVJ3VGV0K2hOdlpjRFdIYjd2Sk5MUT09
-
Categories
- College of Physicians and Surgeons
On behalf of the Herbert Irving Comprehensive Cancer Center, we are pleased to announce the formation of the Columbia Brain Tumor Seminar Series. Seminars will take place on Thursdays at noon in the Florence Irving Auditorium on the first floor of the ICRC Building. The series will feature speakers from outside of Columbia, presenting their work on various aspects of neuro-oncology, ranging from the genes and pathways involved in tumor initiation and metastasis to the roles of the microenvironment and the immune system to novel approaches to therapy and drug delivery. In addition to their seminars, speakers will spend the day meeting with faculty and trainees, learning about the outstanding research happening at Columbia.
Talk Title: “Myeloid heterogeneity and their roles in brain tumors”
Speaker: Dolores Hambardzumyan, PhD, MBA; Professor of Neurosurgery and Oncological Sciences at Mount Sinai School of Medicine
-
Categories
- Basic Health Sciences
- College of Physicians and Surgeons
- Graduate School of Arts and Sciences
- Teaching and Learning
- Research
Using iPSC lines to model human development across individuals
Flora Vaccarino, MD
Harris Professor in the Child Study Center; Director, Program in Neurodevelopment and Regeneration, Child Study Center;
Professor in the Department of Neuroscience
Hosted by Dr. Kristin Baldwin
-
Categories
- Clinical Health Sciences
- College of Physicians and Surgeons
- Mailman School of Public Health
- Research
The Columbia Summer Research Institute & the Biostatistics, Epidemiology, & Research Design resource of the Irving Institute are delighted to announce that we will be hosting a virtual lunchtime seminar on systematic reviews and meta-analyses.
Academic researchers and clinicians interested in developing their skills in research synthesis are welcome to join us on Wednesday, May 15th from 12 – 1pm where we will discuss:
• When to conduct a systematic review & meta-analysis
• How to identify appropriate topics for review
• How to assemble an effective study team
• Learn organizational strategies to guide the project in a reproducible manner
• Review steps of evidence synthesis to gain awareness of resource & time requirements
• Navigate challenges and pitfalls of evidence synthesis, such as handling hidden heterogeneity
Do not miss this free, virtual opportunity to learn how you can enhance your research toolkit!
Speakers: Jeffrey Birk, PhD & Talea Cornelius, PhD MSW
Register here
-
Categories
- College of Physicians and Surgeons
- Basic Health Sciences
Presenters:
AsiaLuna Patlis, Doege Lab
“SH2B1 signaling in iPSC-derived hypothalmic neurons”
Joan Castellano Perez, Taylor Lab
“Aneuploidy impact on basal cell differentiation and lung squamous cell carcinoma development”
-
Categories
- College of Physicians and Surgeons
On behalf of the Herbert Irving Comprehensive Cancer Center, we are pleased to announce the formation of the Columbia Brain Tumor Seminar Series. Seminars will take place on Thursdays at noon in the Florence Irving Auditorium on the first floor of the ICRC Building. The series will feature speakers from outside of Columbia, presenting their work on various aspects of neuro-oncology, ranging from the genes and pathways involved in tumor initiation and metastasis to the roles of the microenvironment and the immune system to novel approaches to therapy and drug delivery. In addition to their seminars, speakers will spend the day meeting with faculty and trainees, learning about the outstanding research happening at Columbia.
Talk Title: “Emerging role of target therapies in Glioma”
Speaker: Macarena de la Fuente, MD; Chief, Neuro-Oncology Division at University of Miami; Clinical Service Leader for Neuro-Oncology Service Line - Sylvester Comprehensive Cancer Center; Chair, Neuro-Oncology Site Disease Group
-
Categories
- Clinical Health Sciences
- Basic Health Sciences
- Mailman School of Public Health
- Research
Title: “Advancing Genomic Discoveries & Implementation: A focus on Underrepresented groups"
Seminar in Precision Medicine series, co-presented by the Center for Precision Medicine and Genomics, the Columbia Precision Medicine Initiative, and the Precision Medicine Resource of the Irving Institute for Clinical and Translational Research. This event is supported in part by a gift from Pfizer to Columbia.
Speaker: Nita A. Limdi, Pharm.D, Ph.D, MSPH, FAHA
Professor Department of Neurology & Epidemiology ; Director, Translational Pharmacogenomics Program; Associate Director, Hugh Kaul Precision Medicine Institute; Co-Director, CTSA Training Academy
With a focus on Drug therapy for Chronic Diseases, Limdi will present how observations at the bedside (as a clinical pharmacist) led her to the bench (research - epidemiologist) to study predictors (including genomics) of drug response.
Over 2 decades, her work has shed light on understanding variability in anticoagulant response in diverse populations - highlighting the influence of genes, comorbid conditions… and the importance of deep clinical phenotyping and robust study design and letting the data drive further exploration
A leader in pharmacogenomics consortia – she has collaborated extensively in evidence reviews and guideline development
Bringing this back to the bedside, she leads implementation of pharmacogenomics at UABHS and will be presenting some of this work
Finally, she will present UAB’s effort and collaborations in eMERGE, developing and returning polygenic risk scores for 10 conditions in a diverse in primary care population
Zoom and in-person. Please register to receive the Zoom link for the event.
Refreshments will be served!
-
Categories
- Basic Health Sciences
- Clinical Health Sciences
The Monthly Columbia Trainee Community Cancer Research Conference features trainees who are engaged in mentored cancer research as part of NIH-funded training grants. These trainees, ranging from predocs to junior faculty, will be given the opportunity to present their ongoing research and career development activities and a chance to network with their peers in the Cancer Center. This event will be hosted by CRTEC every third Thursday of each month from 4 to 5 pm.
We will use a hybrid format for this monthly conference, but all are encouraged to attend in person for pizza and refreshments. The zoom link is https://columbiacuimc.zoom.us/j/91948977720?pwd=L1Ftbk90UU1QTGtYd2FFekR0N1Z4UT09. The passcode is 266728. The in-person location is Conference Room 117, First Floor, Irving Cancer Research Center, 1130 St Nicholas Ave 2nd Floor, New York, NY 10032.
RSVP here.
-
Categories
- Basic Health Sciences
- Clinical Health Sciences
- College of Physicians and Surgeons
- Columbia Nursing
- Core Curriculum
- Education
- Healthcare
- Mailman School of Public Health
- School of Social Work
- Teaching and Learning
Program Overview
IN-PERSON & VIRTUAL CONFERENCE
The application of immunotherapies and cellular therapies in the treatment of cancer have provided tremendous insight into the functions of the immune system. Immunotherapies for solid cancers have greatly enhanced the care of many patients, but have also caused issues in the form of immune-related adverse events, with a multitude of acute and chronic autoimmune complications for patients. Similarly, cellular therapies such as CAR-T cell therapy have significantly improved the treatment of many hematologic malignancies, but have also revealed the potential for these treatments to cause cytokine storm and other severe complications. Research and development of these treatments have taught us a great deal about immune system regulation and dysregulation in general, providing insights into the pathogenesis of autoimmune disease and even stimulating exploration of treatments like CAR-T cell therapy in lupus and PD-1 agonist treatment in rheumatoid arthritis. In this CME course, we bring together the leading national and international experts from oncology, rheumatology, and multiple other specialties to provide a comprehensive overview of the latest insights into diagnosis, management, and future areas of exploration in the realms of cancer and autoimmune disease.
Video Access
Following the program, all registrants will have access to lecture video recordings for ONE month.
Learning Objectives
-Describe the pathobiology and clinical uses of cellular therapy and immunotherapy in cancer
-List the acute and chronic immune-related adverse events in cancer immunotherapy
-Describe the potential complications of cellular therapy in cancer
-Identify treatment strategies to mitigate adverse effects of cellular therapy and immunotherapy in cancer
-Understand the impact of immunotherapy and cellular therapy in patients with pre-existing autoimmune diseases such as systemic lupus erythematosus and rheumatoid arthritis
Joint Accreditation Statement
In support of improving patient care, this activity has been planned and implemented by Amedco LLC and Columbia University. Amedco LLC is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC), to provide continuing education for the healthcare team. Amedco Joint Accreditation #4008163.
Physicians (ACCME) Credit Designation Statement
Amedco LLC designates this live virtual activity for a maximum of 7.25 AMA PRA Category 1 Credits. Physicians should claim only the credit commensurate with the extent of their participation in the activity.
Physician Assistants
PAs may claim a maximum of 7.25 Category 1 credits for completing this activity. NCCPA accepts AMA PRA Category 1 Credit from organizations accredited by ACCME or a recognized state medical society.
Nurse Practitioners
The American Association of Nurse Practitioners (AANP) recognizes the Accreditation Council for Continuing Medical Education (ACCME) and the American Nurses Credentialing Center (ANCC) as approved accreditors and allow reciprocity for AANPCP continuing education credit. Maximum of 7.25 hours.
Pages